MAST ERLE T. - 19 Jan 2022 Form 4 Insider Report for ZOGENIX, INC.

Role
Director
Signature
/s/ Michael P. Smith, Attorney-in-fact for Erle T. Mast
Issuer symbol
N/A
Transactions as of
19 Jan 2022
Net transactions value
-$179,696
Form type
4
Filing time
21 Jan 2022, 20:23:47 UTC
Previous filing
28 May 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZGNX Stock Option (Right to Buy) Options Exercise $94,000 +6,250 +206% $15.04 9,277 19 Jan 2022 Direct F1
transaction ZGNX Stock Option (Right to Buy) Options Exercise $65,100 +4,375 +47% $14.88 13,652 19 Jan 2022 Direct F1
transaction ZGNX Stock Option (Right to Buy) Options Exercise $52,500 +4,375 +32% $12.00 18,027 19 Jan 2022 Direct F1
transaction ZGNX Stock Option (Right to Buy) Sale $391,296 -15,000 -83% $26.09 3,027 19 Jan 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZGNX Stock Option (Right to Buy) Options Exercise $0 -6,250 -100% $0.000000* 0 19 Jan 2022 Common Stock 6,250 $15.04 Direct F1, F3
transaction ZGNX Stock Option (Right to Buy) Options Exercise $0 -4,375 -100% $0.000000* 0 19 Jan 2022 Common Stock 4,375 $14.88 Direct F1, F3
transaction ZGNX Stock Option (Right to Buy) Options Exercise $0 -4,375 -78% $0.000000 1,250 19 Jan 2022 Common Stock 4,375 $12.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2021.
F2 Represents the weighted average sales price per share. The shares were sold at prices ranging from $26.05 to $26.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 All of the shares subject to this option are fully vested and exercisable as of the date hereof.